Led by Dr. Ming Guo, the team identified a new gene involved in the neurological disorder, a finding that could eventually lead to a new target for treatment.
The funding from the California Institute of Regenerative Medicine will support Dr. John Chute's research aimed at creating new stem cell therapies for use in medical practice.
In clinical trials at UCLA, doctors are seeing major treatment successes with an experimental drug called MK-3475 in two types of cancer with historically low survival rates: metastatic melanoma and lung cancer.
"Policymakers should ensure that the impending shift in federal funding does not destabilize institutions that are the backbone of public health in California," UCLA researchers warn.
In less than 40 years, the number of Asian Americans elected or appointed to public office has jumped from just over 100 to more than 4,000, according to a new political almanac published by UCLA.
UCLA researchers have discovered that the parasite that causes trichomoniasis, a common sexual infection, may enhance prostate cells' progression from normal cells to tumor cells.
UCLA-led research at four Los Angeles public schools found that many students didn't eat even a bite of the new, healthier items that were added to menus when LAUSD refreshed its lunch offerings in 2011.
Using an MRI-ultrasound fusion biopsy developed at UCLA, researchers found that nearly a third of men in their study had much more aggressive cancers than originally thought.
First-time violent juvenile offenders sentenced to probation camps are more than twice as likely to be involved in future criminal behavior than youths sentenced to in-home probation.
The UCLA-led team's new approach could lead to new materials with significant improvements in performance, such as self-lubricating bearings for engines, and it may eventually have applications in medicine.
Working alongside physicians and handling a slew of administrative tasks, the partners help doctors save time and give more direct attention to those they treat, a UCLA study shows.
Those patients with additional major medical conditions are more likely to die from something other than cancer, so radiation or surgery represent "a poor gamble," UCLA researchers say.
"It's like your car's airbag, which won’t be deployed unless you really need it," UCLA's Alexander Hoffman said of the specialized immune cells, which use a built-in feedback system to determine which threats are real and which aren't.
Identifying enzyme catalysts that improve the speed and efficiency of the drug-production process can be a major boon. Figuring out exactly why a particular enzyme works so well, UCLA researchers say, is an altogether different quest.
In the late '70s, Marilyn Beaudry-Corbett proved it's never too late to pursue one's dreams, leaving a successful career in the corporate world to study archaeology at UCLA. Now she's giving back.